PURPOSE: This manuscript presents evidence-based guidance on the use of vital pulp therapies for treatment of deep caries lesions in children. A guideline panel convened by the American Academy of Pediatric Dentistry formulated evidence-based recommendations on three vital pulp therapies: indirect pulp t...
BACKGROUND: This manuscript presents evidence-based guidance on the use of 38 percent silver diamine fluoride (SDF) for dental caries management in children and adolescents, including those with special health care needs. A guideline workgroup formed by the American Academy of Pediatric Dentistry develop...
This guideline covers recognition, assessment and monitoring of faltering growth in infants and children. It includes a definition of growth thresholds for concern and identifying the risk factors for, and possible causes of, faltering growth. It also covers interventions, when to refer, service design, ...
This guideline covers increasing immunisation uptake among children and young people aged under 19 years in groups and settings where immunisation coverage is low. It aims to improve access to immunisation services and increase timely immunisation of children and young people. It also aims to ensure babi...
PURPOSE: This manuscript presents evidence-based guidance on the use of vital pulp therapies for treatment of deep caries lesions in children. A guideline panel convened by the American Academy of Pediatric Dentistry formulated evidence-based recommendations on three vital pulp therapies: indirect pulp t...
PURPOSE: This manuscript presents evidence-based guidance on the use of vital pulp therapies for treatment of deep caries lesions in children. A guideline panel convened by the American Academy of Pediatric Dentistry formulated evidence-based recommendations on three vital pulp therapies: indirect pulp t...
BACKGROUND: This article presents evidence-based clinical recommendations for the use of pit-and-fissure sealants on the occlusal surfaces of primary and permanent molars in children and adolescents. A guideline panel convened by the American Dental Association (ADA) Council on Scientific Affairs and the...
Goodman, SM;
Springer, B;
Guyatt, G;
Abdel, MP;
Dasa, V;
George, M;
Gewurz-Singer, O;
Giles, JT;
Johnson, B;
Lee, S;
Mandl, LA;
Mont, MA;
Sculco, P;
Sporer, S;
Stryker, L;
Turgunbaev, M;
Brause, B;
Chen, AF;
Gililland, J;
Goodman, M;
Hurley-Rosenblatt, A;
Kirou, K;
Losina, E;
MacKenzie, R;
Michaud, K;
Mikuls, T;
Russell, L;
Sah, A;
Miller, AS;
Singh, JA;
Yates, A.
OBJECTIVE: This collaboration between the American College of Rheumatology and the American Association of Hip and Knee Surgeons developed an evidence-based guideline for the perioperative management of antirheumatic drug therapy for adults with rheumatoid arthritis (RA), spondyloarthritis (SpA) includin...
Wedzicha, JA;
Calverley, PMA;
Albert, RK;
Anzueto, A;
Criner, GJ;
Hurst, JR;
Miravitlles, M;
Papi, A;
Rabe, KF;
Rigau, D;
Sliwinski, P;
Tonia, T;
Vestbo, J;
Wilson, KC;
Krishnan, JA.
This document provides clinical recommendations for the prevention of chronic obstructive pulmonary disease (COPD) exacerbations. It represents a collaborative effort between the European Respiratory Society and the American Thoracic Society.Comprehensive evidence syntheses were performed to summarise al...
Agonistas de Receptores Adrenérgicos beta 2/uso terapéutico,
Aminopiridinas/uso terapéutico,
Benzamidas/uso terapéutico,
Ciclopropanos/uso terapéutico,
Fluoroquinolonas/uso terapéutico,
Macrólidos/uso terapéutico,
Antagonistas Muscarínicos/uso terapéutico,
Inhibidores de Fosfodiesterasa 4/uso terapéutico,
Progresión de la Enfermedad,
Enfermedad Pulmonar Obstructiva Crónica,
Enfermedad Pulmonar Obstructiva Crónica/tratamiento farmacológico,
Enfermedad Pulmonar Obstructiva Crónica/fisiopatología,
Prevención Secundaria/normas,
Agonistas de Receptores Adrenérgicos beta 2,
Aminopiridinas,
Benzamidas,
Ciclopropanos,
Fluoroquinolonas,
Macrólidos,
Antagonistas Muscarínicos,
Inhibidores de Fosfodiesterasa 4